ROBERT NELSEN

Insider Reports History

Location
Chicago, IL
Signature
/s/ Ryan Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ROBERT NELSEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. Director Common Stock 9,668,749 $178,098,357 $18.42 02 Jun 2021 Held by ARCH Venture Fund VIII, L.P.
Lyell Immunopharma, Inc. Director, 10%+ Owner Common Stock 18,206,358 $41,510,496 $2.28 14 Jun 2024 ARCH Venture Fund IX,L.P.
Lyell Immunopharma, Inc. Director, 10%+ Owner Common Stock 18,206,358 $41,510,496 $2.28 14 Jun 2024 ARCH Venture Fund IX Overage, L.P.
Prime Medicine, Inc. Director, 10%+ Owner Common Stock 6,128,297 $26,658,091 $4.35 01 Aug 2025 By ARCH Venture Fund X, L.P.
Prime Medicine, Inc. Director, 10%+ Owner Common Stock 6,128,297 $26,658,091 $4.35 01 Aug 2025 By ARCH Venture Fund X Overage, L.P.
Prime Medicine, Inc. Director, 10%+ Owner Common Stock 6,230,300 $20,559,990 $3.3 01 Aug 2025 By ARCH Venture Fund XII, L.P.
Vir Biotechnology, Inc. Director Common Stock 584,148 $5,524,697 $9.46 30 May 2024 Direct
Vir Biotechnology, Inc. Director Common Stock 33,893 $320,550 $9.46 30 May 2024 Indirect
Denali Therapeutics Inc. Director Common Stock 12,432 $228,997 $18.42 02 Jun 2021 Direct
Prime Medicine, Inc. Director, 10%+ Owner Common Stock 16,080 $69,948 $4.35 01 Aug 2025 Indirect
Vir Biotechnology, Inc. Director Stock Option (Right to Buy) 16,000 $24,480 $1.53 30 May 2024 Direct
Lyell Immunopharma, Inc. Director, 10%+ Owner Option (right to buy) 130,000 14 Jun 2024 Direct
Sana Biotechnology, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 80,000 05 Jun 2025 Direct
Prime Medicine, Inc. Director, 10%+ Owner Stock Option (right to buy) 45,000 01 Aug 2025 Direct
Denali Therapeutics Inc. Director Stock Option (right to buy) 6,222 02 Jun 2021 Direct
Denali Therapeutics Inc. Director Restricted Stock Units 0 01 Jun 2021 Direct

Insider Reports Filed by ROBERT NELSEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRME Prime Medicine, Inc. 01 Aug 2025 4 $0 4 Director, 10%+ Owner 05 Aug 2025, 20:43
PRME Prime Medicine, Inc. 01 Aug 2025 1 $9,999,990 4 Director, 10%+ Owner 01 Aug 2025, 19:19
SANA Sana Biotechnology, Inc. 05 Jun 2025 1 $0 4 Director, 10%+ Owner 09 Jun 2025, 16:39
PRME Prime Medicine, Inc. 04 Jun 2025 1 $0 4 Director, 10%+ Owner 05 Jun 2025, 18:13
LYEL Lyell Immunopharma, Inc. 14 Jun 2024 1 $0 4 Director, 10%+ Owner 17 Jun 2024, 16:41
PRME Prime Medicine, Inc. 12 Jun 2024 1 $0 4 Director, 10%+ Owner 14 Jun 2024, 16:59
SANA Sana Biotechnology, Inc. 06 Jun 2024 1 $0 4/A Director, 10%+ Owner 15 Jul 2024, 16:12
SANA Sana Biotechnology, Inc. 06 Jun 2024 1 $0 4 Director, 10%+ Owner 07 Jun 2024, 16:22
VIR Vir Biotechnology, Inc. 30 May 2024 2 $0 4 Director 03 Jun 2024, 12:14
PRME Prime Medicine, Inc. 15 Feb 2024 1 $20,000,000 4 Director, 10%+ Owner 20 Feb 2024, 17:41
SANA Sana Biotechnology, Inc. 08 Feb 2024 3 $9,999,995 4 Director, 10%+ Owner 12 Feb 2024, 17:46
LYEL Lyell Immunopharma, Inc. 08 Sep 2023 1 $0 4 Director, 10%+ Owner 08 Sep 2023, 16:24
LYEL Lyell Immunopharma, Inc. 16 Jun 2023 1 $0 4 Director, 10%+ Owner 20 Jun 2023, 16:49
PRME Prime Medicine, Inc. 14 Jun 2023 1 $0 4 Director, 10%+ Owner 16 Jun 2023, 17:49
SANA Sana Biotechnology, Inc. 08 Jun 2023 1 $0 4 Director, 10%+ Owner 12 Jun 2023, 17:42
VIR Vir Biotechnology, Inc. 22 May 2023 2 $0 4 Director, 10%+ Owner 24 May 2023, 16:16
SANA Sana Biotechnology, Inc. 05 Jan 2023 1 $0 4 Director, 10%+ Owner 06 Jan 2023, 15:19
PRME Prime Medicine, Inc. 24 Oct 2022 10 $13,600,000 4 Director, 10%+ Owner 26 Oct 2022, 20:01
PRME Prime Medicine, Inc. 19 Oct 2022 0 $0 3/A Director, 10%+ Owner 24 Oct 2022, 16:40
SANA Sana Biotechnology, Inc. 05 Oct 2022 1 $0 4 Director, 10%+ Owner 06 Oct 2022, 16:06
VIR Vir Biotechnology, Inc. 02 Sep 2022 8 $0 4 Director, 10%+ Owner 07 Sep 2022, 20:30
VIR Vir Biotechnology, Inc. 30 Aug 2022 8 $0 4 Director, 10%+ Owner 01 Sep 2022, 17:22
VIR Vir Biotechnology, Inc. 24 Aug 2022 8 $0 4 Director, 10%+ Owner 26 Aug 2022, 17:15
VIR Vir Biotechnology, Inc. 18 Aug 2022 4 $0 4 Director, 10%+ Owner 22 Aug 2022, 17:15
VIR Vir Biotechnology, Inc. 12 Aug 2022 12 $0 4 Director, 10%+ Owner 16 Aug 2022, 21:05
SANA Sana Biotechnology, Inc. 05 Jul 2022 1 $0 4 Director 07 Jul 2022, 16:30
VIR Vir Biotechnology, Inc. 08 Jun 2022 4 $0 4 Director, 10%+ Owner 10 Jun 2022, 21:24
LYEL Lyell Immunopharma, Inc. 08 Jun 2022 1 $0 4 Director, 10%+ Owner 10 Jun 2022, 16:18
SANA Sana Biotechnology, Inc. 06 Jun 2022 1 $0 4 Director 08 Jun 2022, 18:31
VIR Vir Biotechnology, Inc. 02 Jun 2022 3 $0 4 Director, 10%+ Owner 06 Jun 2022, 20:25
VIR Vir Biotechnology, Inc. 23 May 2022 2 $0 4 Director, 10%+ Owner 25 May 2022, 18:38
SANA Sana Biotechnology, Inc. 05 Apr 2022 1 $0 4 Director 06 Apr 2022, 17:54
VIR Vir Biotechnology, Inc. 20 Dec 2021 1 $0 4/A Director, 10%+ Owner 10 May 2022, 17:26
VIR Vir Biotechnology, Inc. 29 Nov 2021 3 $0 4 Director, 10%+ Owner 01 Dec 2021, 17:31
VIR Vir Biotechnology, Inc. 22 Nov 2021 3 $0 4 Director, 10%+ Owner 24 Nov 2021, 16:59
VIR Vir Biotechnology, Inc. 01 Jul 2021 3 $0 4 Director, 10%+ Owner 06 Jul 2021, 16:48
VIR Vir Biotechnology, Inc. 22 Jun 2021 3 $0 4 Director, 10%+ Owner 24 Jun 2021, 17:05
LYEL Lyell Immunopharma, Inc. 21 Jun 2021 6 $0 4 Director, 10%+ Owner 23 Jun 2021, 17:38
LYEL Lyell Immunopharma, Inc. 16 Jun 2021 0 $0 3 Director, 10%+ Owner 16 Jun 2021, 19:20
DNLI Denali Therapeutics Inc. 02 Jun 2021 2 $0 4 Director 04 Jun 2021, 18:35
VIR Vir Biotechnology, Inc. 21 May 2021 2 $0 4 Director, 10%+ Owner 25 May 2021, 16:44
DNLI Denali Therapeutics Inc. 22 Mar 2021 6 $0 4 Director 03 Jun 2021, 20:55